VEDR01 Versa DR
Implantable Pulse Generator (IPG)
VEDR01 Versa DR
Information

Device Survival Probability

VEDR01_SURV
Loading...










    1 yr 2 yr 3 yr 4 yr 5 yr 6 yr 7 yr 8 yr 9 yr 10 yr 11 yr 12 yr at 150.0 mo                
% Excluding Normal Battery Depletion 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0                
% Including Normal Battery Depletion 99.8 99.7 99.6 99.4 99.0 98.3 96.6 90.5 75.7 57.6 42.9 30.7 22.6                
#   99229 90636 82500 74378 65636 57554 49208 39010 25862 14169 6477 1694 226                
  • Including Normal Battery Depletion – This curve includes devices that have reached at least 80% of expected longevity. This curve is most representative of clinical performance and how long the device will last.
  • Excluding Normal Battery Depletion – This is the malfunction free survival curve.
Information

Customer Communications For This Model

Information

Product Characteristics

Generator Type IPG
NBD Code DDDR
Max. Delivered Energy N/A
More
Connector Style IS-1 UNI/BI
Serial Number Prefix NWH, PWH
Mass 27.1 g
Volume 12.1 cc
Waveform N/A
X-Ray ID PWH, PWB
Hide this content
IS-1 UNI/BI
Information

Estimated Longevity

Amplitude Setting 500 Lead Ω 1000 Lead Ω
Low 2.5 V (A, RV) 7.4 | 9.1* 8.2 | 10.3*
Nominal 3.5 V (A, RV) 6.0 | 7.2* 7.4 | 9.0*
High 5.0 V (A, RV) 4.5 | 5.1* 6.0 | 7.0*
Footnote

*The second longevity numbers provided apply to the N-series Versa VEDR01 product. The N-series products have increased longevity because of improved electronic circuitry. Click on "Other Articles" for more information on the N-series longevity. Longevity estimates based on the following device usage. Pace/Sense Mode DDD ; Atrial Pulse Width 0.4 ms; Right Ventricle Pulse Width 0.4 ms; Lower Pace Rate 60 bpm; Right Ventricle Percent Paced 100 %; EGM Prestorage ON ; Upper Sensing Rate 130 ppm; Atrial Percent Paced 100 %; EGM Prestorage ON Time 1 ; Atrial Fib Percent of Time 0 %Hide this content

Information

Distribution Data

US Market Release2006-07-17
CE Approval Date2005-09-20
Registered USA Implants118831
Estimated Active USA Implants30610
Normal Battery Depletions11355
US Market Release2006-07-17
CE Approval Date2005-09-20
Estimated WW Distribution178057
Normal Battery Depletions11397
Information

Malfunctions (USA)

Therapy Function Not Compromised 11
Electrical Component 7
Electrical Interconnect 2
Possible Early Battery Depletion 2
Therapy Function Compromised 14
Electrical Component 10
Other 4
Information

Malfunctions (WW)

Therapy Function Not Compromised 18
Electrical Component 14
Electrical Interconnect 2
Possible Early Battery Depletion 2
Therapy Function Compromised 18
Electrical Component 14
Other 4
Information

EOS Indication

Prolonged Service period is 3 months after RRT/ERI assuming 100% pacing at the listed parameter settings. Reprogramming of pacing parameters may reduce the duration of the prolonged service period.

Information

Recommended Replacement (RRT)

Telemetry indication. Rate and Mode change to 65 ppm and VVI (VOO/65 with magnet).

Data as of December 16, 2021

www.medtronic.com/productperformance 851050